FDA Clears PXS Cancer Drug for Phase 2 Liver Cancer Study
Filed with ASX · · 3 pages · English
Story so far
Earlier from Syntara
- Appendix 4C Cash Flow Report
- PXS Doses First Patient in Phase 2 Bone Marrow Cancer Trial
- PXS Cleared to Progress to Phase 2 Bone Marrow Cancer Trial
- Pharmaxis Treatment to Prevent Wound and Burns Scars Clears
- PXS Grants Exclusive Option to Develop High Payload Inhaler
Later from Syntara
- Security Purchase Plan
- Share Purchase Plan
- PXS Collaborators Receive Government Grants of $1.4m
- Response to ASX Aware Query
- Appendix 4C Quarterly Cash Flow Report
Follow Syntara into a list and get an email when it puts out news.
Follow Syntara